🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
MAZ
$MAZE
🔒 US EquitiesMaze Therapeutics Inc
AVG HISTORICAL GAP
-3.63%
MAX GAP RECORD
-18.37%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $MAZE
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$MAZE
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (21:00)) | 🔮 UPCOMING 🔒 |
| Aug 18, 2026 Earnings Release 2026-08-18 (AFTER CLOSE) |
+1.99%
|
| Mar 25, 2026 Earnings Release 2026-03-25 (BEFORE OPEN) |
-18.37%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
+0.81%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+1.89%
|
| Mar 31, 2025 Earnings Release 2025-03-31 (BEFORE OPEN) |
-4.47%
|
| Jan 31, 2025 Earnings Release 2025-01-31 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.5%
Bullish Gaps (2)
Bearish Gaps (2)
Neutral / Flat (1)
📖 Intelligence Summary
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗